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CcpA mediates the catabolite repression of tst in Staphylococcus
aureus
Abstract
Some clinical isolates of Staphylococcus aureus produce the superantigenic toxic shock syndrome toxin
TSST-1, encoded by tst and located on pathogenicity islands. The expression of tst is complex, and
influenced by environmental conditions such as pH, CO2 and glucose. We identified a putative
catabolite responsive element (cre) in the promoter region of all known tst genes, indicating that tst
transcription may be regulated by the catabolite control protein CcpA. By introducing tst-genes under
their native promoter or tst-promoter-reporter gene fusions in wild type strain Newman, we showed that
glucose was able to repress tst transcription and TSST-1 production, whereas glucose repression was
abolished in the corresponding DeltaccpA mutant. Stabilizing the pH ruled out a pH effect due to acid
production during glucose catabolism. CcpA thus directly regulates tst transcription, linking
carbohydrate utilization to virulence gene expression in S. aureus.
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Some clinical isolates of Staphylococcus aureus produce the superantigenic toxic shock syndrome toxin 1
(TSST-1), encoded by tst, located on pathogenicity islands. The expression of tst is complex and is influenced
by environmental conditions such as pH, CO2, and glucose. We identified a putative catabolite-responsive
element (cre) in the promoter regions of all known tst genes, indicating that tst transcription may be regulated
by the catabolite control protein CcpA. By introducing tst genes under the control of their native promoters or
tst promoter-reporter gene fusions in wild-type strain Newman, we showed that glucose was able to repress tst
transcription and TSST-1 production, whereas glucose repression was abolished in the corresponding ccpA
mutant. Stabilizing the pH ruled out a pH effect due to acid production during glucose catabolism. CcpA thus
directly regulates tst transcription, linking carbohydrate utilization to virulence gene expression in S. aureus.
Toxic shock syndrome (TSS) is an acute and potentially fatal
illness caused by a group of bacterial superantigens, such as
toxic shock syndrome toxin 1 (TSST-1), staphylococcal en-
terotoxins, and streptococcal pyrogenic toxins. Superantigens,
unlike conventional peptide antigens, bind to invariant regions
of the major histocompatibility complex class II molecules at
the surfaces of antigen-presenting cells, outside the classical
antigen-binding groove, and also to invariant regions of the
T-cell receptor. This leads to activation of T cells at orders of
magnitude above that for antigen-specific activation, resulting
in massive cytokine release, which in turn leads to capillary
leakage and is believed to be responsible for hypotension,
shock, and finally, death (19). Especially in the early 1980s,
there was a major interest in TSS because there were several
staphylococcal TSS cases reported for otherwise healthy young
women (7). This rise in TSS cases was associated with high-
absorbency tampons, and the disease was named menstrual
TSS. In most cases, menstrual TSS is associated with TSST-1,
but cases of nonmenstrual TSS have also been associated with
this toxin (8, 9), which is encoded by tst, a gene found on
several staphylococcal pathogenicity islands (SaPIs) (reviewed
in reference 25).
The regulation of TSST-1 is known to be complex, and
several environmental conditions, including salt, oxygen, car-
bon dioxide, growth rate, temperature, glucose, and pH, were
reported to modulate its production (3, 29, 31, 46). Global
regulators shown to be involved in the regulation of TSST-1
are SarA (4, 6, 23), RNAIII of the agr system (3, 28), and
SrrAB (45) (Fig. 1). However, there is some contradiction
about the role of SarA in tst expression, since Chan and Foster
(4) described that repression of tst by SarA was agr indepen-
dent, while Novick (23) found that tst repression was depen-
dent on agr. SrrAB, which is also a repressor of RNAIII (27),
was previously shown to repress tst transcription under limited
oxygen pressure (45). More recently, Pragman et al. (26) pro-
posed that SrrAB, in addition to its downregulatory function
under low-oxygen conditions, enhances the level of tst under
aerobic conditions. More complexity is added by the fact that
tst has autoregulatory functions, with TSST-1 acting as a re-
pressor of tst transcription (41) (Fig. 1).
We recently analyzed the impact of the carbon catabolite
protein A (CcpA) of Staphylococcus aureus on carbon metab-
olism, virulence determinant expression, and biofilm formation
(34, 35). CcpA induces or represses the transcription of genes
by binding to so-called catabolite-responsive elements (cre)
(33). These cis-acting DNA sequences, which consist of 14 to
18 bp, have been studied extensively in Bacillus subtilis (17, 20,
21, 38, 44, 47). Binding of CcpA to the cre sites is induced by
complex formation with HPr, a component of the phosphoenol-
pyruvate-dependent phosphotransferase transport system (32, 37,
43). In the presence of glucose or other rapidly metabolized
carbon sources, HPr is phosphorylated on serine-46 and binds to
CcpA. But CcpA can apparently also regulate gene expression
without binding to cre sites (12–14, 22). It was proposed that
CcpA can directly interact with and inhibit RNA polymerase, in a
process that is stimulated by NADP or NADPH, independent of
the redox state of the cell (14).
Since TSST-1 production was shown to be repressed by
glucose (31) and since our in silico analysis of the sequenced S.
aureus genomes identified putative cre sites in the tst promoter
regions, we investigated whether CcpA was the mediator of
this regulatory phenomenon. We therefore analyzed the effects
of glucose on tst transcription and TSST-1 production and
compared them to the effects in a ccpA null mutant. Our
results indicate that repression of tst by glucose is mediated
directly by the carbon catabolite protein CcpA.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. The bacterial strains,
relevant phenotypes, and plasmids used in this study are listed in Table 1. All
strains generated for this study were confirmed by pulsed-field gel electrophore-
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sis of total genomic SmaI digests (42) and by Southern blot analysis according to
standard protocols, using CcpA- and RNAIII-specific digoxigenin (DIG)-labeled
probes, which were generated using previously published primers (35). S. aureus
was routinely grown in Luria-Bertani (LB) medium buffered with 50 mM HEPES
(pH 7.5), with a flask volume/culture volume ratio of 5:1, at 37°C and 200 rpm.
The medium was supplemented with 50 g ml1 kanamycin and 10 g ml1
tetracycline, if appropriate.
Construction of plasmid tstpN315::luc-pCN34 (pSKA12). A 0.8-kb fragment
containing the tst promoter region was amplified by PCR from chromosomal
DNA of S. aureus N315 by the use of primers TstPAsp718 (GCGCCATGGT
TAATTCTCCTTCATTCAAA), including an Asp718 linker (underlined), and
TstPNcoI (GCGGGTACCTTCGAGAGGCAGATTACTCC), including an
NcoI linker (underlined). The PCR product was cloned in front of the luciferase
gene of plasmid pSPluc. From this plasmid, a 2.4-kb Asp718-EcoRI fragment,
including the tst promoter region fused to the luciferase coding region, was
cloned into plasmid pCN34, generating plasmid pSKA12. The identity of the
construct was confirmed by sequence analysis and comparison to the respective
N315 sequence in the NCBI database (accession no. NC_002745). The plasmid
was electroporated into strain RN4220 and subsequently transduced into strain
Newman and its isogenic ccpA mutant (MST14). The plasmid was also intro-
duced into strain Newman agr (KS186), which was obtained by transduction of
agr::tet(M) from strain RN6911.
Construction of plasmids tstN315-pAW17 (pSKA20) and tstRF122-pAW17
(pSKA21). One-kilobase fragments containing tst and its promoter region were
amplified by PCR from chromosomal DNAs of S. aureus N315 and RF122, using
primers TstXbaI (GTTGTCTAGAACTCACACTTTGTTTTTTGC), includ-
ing an XbaI linker (underlined), and TstPstI (GTTGCTGCAGGTTTACTA
ATTCACCCTAGC), including a PstI linker (underlined). The PCR products
were cloned into pAW17, generating pSKA20 and pSKA21, respectively. The
identities of the constructs were confirmed by sequence analysis and comparison
to the respective sequences in the NCBI database (for N315, accession no.
NC_002745; and for RF122, accession no. NC_007622). The plasmids were
electroporated into RN4220 and subsequently transduced into strain Newman,
its respective ccpA mutant (MST14), strain Newman agr (KS186), and strain
RN450.
Luciferase assays. For glucose impulse experiments, the cultures were inocu-
lated at an optical density at 600 nm (OD600) of 0.05 and were grown for 5 h
without glucose. At this time point, corresponding to the early stationary growth
phase, the cultures were split and different amounts of glucose were added.
Samples were taken 0, 30, and 60 min after the glucose impulse. To follow the tst
promoter-luciferase reporter activity over time, the medium was inoculated with
an overnight culture to an OD600 of 0.05 and the bacteria were grown for 8 h. The
medium contained either 10 mM glucose or no glucose. Sampling was performed
on an hourly basis, starting 2 h after inoculation. Luciferase activity was mea-
sured as described earlier, using a luciferase assay substrate and a Turner De-
FIG. 1. Regulation of tst transcription. Arrows represent upregu-
lation, bars represent downregulation, dashed arrows indicate contro-
versial findings, and numbers in parentheses indicate references. The
question mark corresponds to CcpA.
TABLE 1. Bacterial strains and plasmids
Strain or plasmid Relevant genotype and/or phenotypea Source or reference
Strains
S. aureus strains
RN4220 NCTC8325-4 r m (restriction negative, modification positive) 15
RN6911 NCTC8325-4 agr::tet(M) Tcr 40
Newman ATCC 25904; clinical isolate, CP5 producer 10
MST14 Newman ccpA::tet(L) Tcr 35
N315 Multiresistant clinical methicillin-resistant S. aureus isolate, TSST-1 producer 16
RF122 Wild-type strain from bovine mastitis, TSST-1 producer 11
RN450 NCTC8325-4 24
KS87 Newman/pSKA12 (tstpN315::luc
) Kanr This study
KS64 Newman ccpA::tet(L)/pSKA12 (tstpN315::luc
) Tcr Kanr This study
KS179 Newman/pSKA20 (tstN315
) Kanr This study
KS180 MST14/pSKA20 (tstN315
) Tcr Kanr This study
KS181 Newman/pSKA21 (tstRF122
) Kanr This study
KS182 MST14/pSKA21 (tstRF122
) Tcr Kanr This study
KS186 Newman agr::tet(M) Tcr This study
KS187 Newman agr::tet(M)/pSKA12 (tstpN315::luc
) Tcr Kanr This study
KS188 Newman agr::tet(M)/pSKA20 (tstN315
) Tcr Kanr This study
KS189 Newman agr::tet(M)/pSKA21 (tstRF122
) Tcr Kanr This study
KS197 RN450/pSKA20 (tstN315
) Kanr This study
KS198 RN450/pSKA21 (tstRF122
) Kanr This study
E. coli strain
DH5 Restriction-negative strain for cloning Invitrogen
Plasmids
pSPluc Luciferase fusion plasmid, ColE1 replication origin; Apr Promega
pCN34 E. coli-S. aureus shuttle plasmid, ColE1 replication origin; pT181 cop-wt repC; Ampr Kanr 5
pAW17 E. coli-S. aureus shuttle plasmid, ColE1 and pAM1 replication origins; Kanr 30
pSKA12 pCN34 containing a 2.5-kb tstpN315::luc
 fusion; Apr Kanr This study
pSKA20 pAW17 with a 1-kb PCR fragment covering tst of strain N315 and its proposed promoter; Kanr This study
pSKA21 pAW17 with a 1-kb PCR fragment covering tst of strain RF122 and its proposed promoter; Kanr This study
a Tcr, tetracycline resistant; Kanr, kanamycin resistant; Apr, ampicillin resistant.
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signs TD-20/20 luminometer (Promega) (1). All luciferase assays were per-
formed at least three times in independent experiments.
Northern blots. Sampling for Northern blot analysis was performed basically
as described for the glucose impulse experiments in the luciferase assays. Ten
millimolar glucose was added to one-half of the culture, while the other half
remained without glucose. Samples were centrifuged for 2 min at 12,000 g, and
cell sediments were snap-frozen in liquid nitrogen. RNA isolation and Northern
blotting were performed as described earlier (18). Primers DIGtst (TAAGC
CTTTGTTGCTTGCG) and DIGtst (CACTTTGATATGTGGATCCG) were
used to generate DIG-labeled tst probes. All Northern blot analyses were per-
formed at least twice with independently isolated RNA samples.
Exoprotein analysis and Western blots. For the determination of TSST-1
levels in the supernatants, cells were grown for 3 or 5 h either with or without 10
mM glucose. Supernatants were adjusted to the same volume for all samples,
using sterile medium. Identical amounts of bovine serum albumin were added to
samples as an internal control for semiquantitative detection of TSST-1. Proteins
were precipitated with trichloroacetic acid at a final concentration of 10%,
samples were placed on ice for 30 min and centrifuged for 15 min at 16,000  g,
and sediments were washed twice with 5 ml acetone. After being air dried,
sediments were resuspended in loading buffer and samples corresponding to a
final OD600 of 0.25 (1.25 for strain N315) were analyzed by 10% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis. Gels were either stained with Coo-
massie brilliant blue or blotted on nitrocellulose membranes. TSST-1 detection
was performed using rabbit polyclonal anti-TSST-1 antibodies (LucernaChem,
Switzerland) after blocking with human immunoglobulin G and visualized using
SuperSignal West Pico chemiluminescent substrate (Pierce, Rockford, IL).
For the determination of exoprotein patterns, cells were sampled at an OD600
of 3.5 (5 h). Proteins were precipitated as described above, and samples
corresponding to a final OD600 of 1.0 were analyzed by 10% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and stained with Coomassie brilliant
blue or blotted for TSST-1 detection as described above.
Determination of glucose levels. Two-milliliter aliquots of bacterial cultures
were harvested at the indicated time points and centrifuged for 2 min at 16,000 g.
The supernatants were incubated at 80°C for 15 min and stored at 20°C until
use. Glucose levels were determined with kits from R-Biopharm (Darmstadt,
Germany) according to the manufacturer’s directions.
RESULTS AND DISCUSSION
The tst promoter region contains a cre site. By screening
strain N315 with the consensus sequence proposed by Miwa et
al. (21), we identified a putative cre site 22 bp upstream of the
translational start of tst on SaPIn1 (Fig. 2). Because tst is
located on different pathogenicity islands (SaPIs) in different
strains (25), we compared the promoter regions of the tst genes
of the published SaPIs (SaPIn1 [strain N315], GenBank acces-
sion no. NC_002745; SaPm1 [strain Mu50], NP_372535; SaPI1
[strain RN4282], U93688; SaPI2 [strain RN3984], EF010993;
and SaPbov1 [strain RF122], NC_007622). We found identical
cre sites on SaPI1, SaPIm1, SaPIn1, and SaPI2 (data not
shown). With the exception of 1 bp, the cre sites were palin-
dromic and were located downstream of the transcriptional
start site suggested by Vojtov et al. (41). The pathogenicity
island SaPIbov1 of the bovine mastitis isolate RF122 had a cre
site which differed at 2 bp from the cre sites of the other tst
genes. However, it was still palindromic with the exception of
1 bp (Fig. 2).
tst expression is strongly repressed in the presence of glu-
cose. The presence of cre sites in the different tst genes together
with previous findings showing that glucose decreased TSST-1
production (31) indicated that CcpA might mediate glucose-
induced tst repression. To confirm that glucose also had an
effect on tst transcription, we performed a Northern blot anal-
ysis in a glucose impulse experiment. We chose strains N315
and RF122 to compare the two different cre variants. Because
tst is known to be expressed in early stationary growth phase
(39), we cultured the cells in buffered medium for 5 h, split the
cultures, and added glucose to one-half of each culture. In line
with the literature, we found strong tst transcription in RF122
during this growth stage, while the addition of glucose led to a
clear repression of tst (Fig. 3A). Surprisingly, in strain N315, tst
expression was much weaker and smears appeared instead of a
distinct band, impeding an interpretation of the glucose effect
(data not shown). To see if the glucose-dependent activation of
CcpA was functional in this particular strain, we tested the
glucose-mediated repression of pckA, a gene previously re-
ported to be under the control of CcpA (35). We observed a
strong glucose-dependent repression of pckA, indicating that
N315 possessed a functional CcpA protein (data not shown).
To determine the influence of the genetic background on tst
expression in N315, we fused the promoter region of the tst
gene of this strain to the firefly luciferase gene, yielding plas-
mid tstpN315::luc
-pCN34 (pSKA12), and transduced the con-
struct into strain Newman. The luciferase activity in the trans-
formed Newman derivative reached high values of between
30,000 and 50,000 relative light units. By testing the impact of
the glucose concentration on tst repression, we observed that
the addition of 1 mM (0.018%) glucose reduced the luciferase
activity to 66% (8.5%), 2 mM (0.036%) glucose decreased
the activity to 35% (7.0%), and concentrations of 	4 mM
decreased the activity to 
18% (8.0%) (Fig. 3B). This indi-
cated that transcription of the tst promoter of N315 was highly
sensitive to low concentrations of glucose and suggested that
the low tst expression in N315 was likely due to the genetic
background.
FIG. 2. Alignment of the cloned tst promoter regions of strains N315 (GenBank accession no. NC_002745; nucleotides 2,060,871 to 2,061,078)
and RF122 (GenBank accession no. NC_007622; nucleotides 400,656 to 400,452) used for the construction of pSKA20 and pSKA21. The ribosome
binding site (rbs) suggested by Blomster-Hautamaa et al. (2) is shown. Nucleotides fitting with the cre consensus of B. subtilis suggested by Miwa
et al. (21) are highlighted in bold. Inverted repeats are indicated by arrows. Differences in nucleotides are highlighted by gray boxes.
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Glucose-dependent repression of tst transcription requires
CcpA. To assess the impact of CcpA on the glucose-dependent
repression of tst transcription, we transduced the tstpN315::
luc-pCN34 construct into the ccpA mutant of strain New-
man and followed the glucose effect over time in the wild-type
and mutant strains. In the wild type, repression of luciferase
activity was already clearly detectable 30 min after glucose addi-
tion, and activity decreased further until 1 h after glucose addition
(Fig. 4). The pH remained stable throughout the time course
followed, ruling out a possible pH effect on tst expression (31). In
the mutant, no changes in activity were observed upon glucose
addition, strongly suggesting that CcpA was involved in glucose-
mediated tst repression (Fig. 4).
To observe the long-term effects of glucose on tst promoter
activity during growth, the wild-type and ccpA mutant strains
were grown for 8 h in either the presence or absence of glu-
cose, and luciferase activity was followed at 1-h intervals. With-
out glucose, activity in the wild type started to rise after 3 h,
reached its maximum after 5 h, and remained stable from then
on (Fig. 5A). In the presence of glucose, activity remained very
low (about 1% of the activity without glucose) and started to
rise only slowly after 5 h, when glucose was depleted from the
medium, reaching a similar value to that for cells grown with-
out glucose after 8 h (Fig. 5A and B). Despite HEPES buff-
ering, in the presence of glucose, the pH dropped slightly after
5 h (Fig. 5B). For the mutant, luciferase activities were similar
in the presence and absence of glucose, and the pH remained
stable under both conditions for up to 7 h (Fig. 5A and B).
Compared with that of the wild type, luciferase activity in the
mutant rose faster and tended to be higher.
The luciferase assays left the question open of whether and
how CcpA would repress tst transcription in the presence of an
intact tst gene. Unfortunately, we were not successful in trans-
ducing the ccpA mutation into strain N315, strain RF122, or
other clinical TSST-1-expressing isolates from our strain col-
lection. We therefore introduced the tst genes of strains N315
and RF122 (tstN315 and tstRF122, respectively) in trans into
strain Newman and its ccpA mutant. The plasmid-borne tst
transcripts were the same size (1 kb) as the chromosomal tst
transcripts of strains N315 and RF122 (data not shown). Even
FIG. 3. Influence of glucose on tst expression. (A) Northern blot
analysis of tst expression in response to glucose in strain RF122 after
the addition of 10 mM glucose to a culture in the early stationary
growth phase. Ethidium bromide-stained 23S rRNA indicates RNA
loading. (B) Luciferase activity of strain KS87 in response to different
glucose concentrations. The luciferase activity at time zero was set to
100% (dashed line), and relative activity after 60 min was assessed. The
averages of three independent measurements are shown. Error bars
indicate the standard deviations of the mean activities. **, P
 0.01 for
supplemented versus unsupplemented cultures. (C) tst transcription in
response to glucose in strains Newman (wt) and MST14 (ccpA)
carrying pSKA20 (tstN315) or pSKA21 (tstRF122) after the addition of 10
mM glucose to a culture in the early stationary growth phase. Ethidium
bromide-stained 23S rRNA indicates RNA loading. The exposure time
of tstN315 had to be adjusted in comparison to that of tstRF122.
FIG. 4. Relative luciferase activities of strains KS87 (wt), KS64
(ccpA), and KS187 (agr). Glucose (10 mM) was added to one-half
of a culture in the early stationary growth phase (black bars), while the
other half remained without glucose (white bars). Activity at time zero
was set to 100% (dashed line), and relative activities after 30 and 60
min were assessed. The averages of three independent measurements
are shown. Error bars indicate the standard deviations of the mean
activities. **, P 
 0.01 for supplemented versus unsupplemented cul-
tures.
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though the higher copy number of the plasmid-carried tstN315
and tstRF122 genes may blur a CcpA effect in strains KS181 and
KS179, tst transcription in the respective Newman ccpA mu-
tants KS182 and KS180 was lower than that in the wild type,
indicating that CcpA might exert some regulatory function on
tst expression even in the absence of glucose (Fig. 3C). The
overall apparently stronger tstN315 transcription, although it
was cloned into the same plasmid backbone as tstRF122 and
expressed in the same Newman background, may be due to
small sequence differences in the operator region (Fig. 2) or
possibly also within the coding or terminator region (not
shown).
In performing glucose impulse experiments with the strains
carrying the tst-expressing plasmids, we found strong repres-
sion of tst transcription by glucose in strain Newman, indepen-
dent of whether it carried the N315 or RF122 tst variant.
However, no such effect was observed in the ccpA mutant
(Fig. 3C). The finding that both tst genes were repressed by
glucose in a CcpA-dependent manner suggests that the minor
difference in their cre sites did not affect CcpA activity.
tst does not affect exoprotein patterns in LB medium. To
assess TSST-1 production and the impact of TSST-1 on the
exoprotein patterns of the different strains, we analyzed super-
natants of post-exponential-growth-phase cultures. Consistent
with its low tst transcription, strain N315 produced significantly
smaller amounts of TSST-1 than those in RF122 or Newman
carrying the tst plasmids after 5 h of growth (data not shown).
The production of larger TSST-1 amounts in KS179 (Newman
tstN315) than in KS181 (Newman tstRF122) (Fig. 6A) was in line
with the stronger tstN315 transcription in this strain.
Unlike Vojtov et al. (41), who found a strong difference
in exoprotein production between TSST-1-producing isolates
and their isogenic non-TSST-1-producing strains in CYGP me-
dium (Casamino Acids [10 g/liter]; yeast extract [10 g/liter],
NaCl [5 g/liter], 20% glucose, 1.5 M phosphoglycerate), we did
not observe such differences between the TSST-1-producing
derivatives of strain Newman and the parental strain in LB
medium (Fig. 6A). Transducing the tst-expressing plasmids
into strain RN450 (NCTC8325-4 agr), a background similar
to the one used by Vojtov et al. (41), did not change the
FIG. 5. tst promoter activity and growth characteristics of KS87 (wt) and KS64 (ccpA) in the presence (squares) and absence (triangles) of
glucose. (A) Luciferase activity and glucose consumption. rlu, relative light units. (B) Growth and pH. Data are representative of three independent
measurements.
FIG. 6. Influence of TSST-1 production on exoprotein patterns and
influence of ccpA deletion on TSST-1 production in response to glu-
cose. (A) Exoprotein patterns and TSST-1 production of strains New-
man, KS179 (Newman tstN315), KS181 (Newman tstRF122), RN450,
KS197 (RN450/pSKA20 tstN315), and KS198 (RN450/pSKA21tstRF122)
at an OD600 of 3.5. The arrow indicates the position of TSST-1.
(B) Comparison of TSST-1 production in response to glucose in strains
KS179 (Newman tstN315), KS180 (Newman ccpA tstN315), and RF122
after 3 h of growth.
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exoprotein pattern in comparison to that of the wild type (Fig.
6A), suggesting that this effect may be medium dependent. As
already found in the Newman background, tst transcription and
TSST-1 production (Fig. 6A) were stronger when RN450 car-
ried the tstN315 gene than when it carried tstRF122.
Glucose affects TSST-1 production in a CcpA-dependent
manner. To confirm that the observed glucose-mediated re-
pression of tst transcription also affected TSST-1 production,
we determined the TSST-1 contents in the supernatants of
KS179 (Newman tstN315) and KS180 (Newman ccpA tstN315)
cell cultures after 3 h of growth in the presence and absence of
10 mM glucose. In the presence of glucose, KS179 reached a
higher OD600 than that in the absence of glucose, while no
such difference in OD600 was found for strain KS180. In line
with the transcriptional data, we found a clear decrease in
TSST-1 in the supernatant of strain KS179 grown in the pres-
ence of glucose, while the TSST-1 levels in the supernatants
of the ccpA mutant KS180 were almost identical in the
presence and absence of glucose (Fig. 6B). Glucose also led
to a higher OD600 in strain RF122 and repressed TSST-1
production (Fig. 6B).
Repression of tst expression by CcpA in an agr-null mutant.
Strain N315 was previously reported to have defective RNAIII
production (36). Since RNAIII is a known inducer of tst tran-
scription (3, 28), this may explain the low tst transcription levels
in N315. We confirmed that agr inactivation in strain Newman
strongly reduced tstN315 and tstRF122 transcription (data not
shown). The low level of tst transcription observed in N315,
which harbors a functional CcpA system, might therefore be
due, at least in part, to the lack of RNAIII. Nevertheless, by
luciferase assays, we observed glucose-mediated repression of
tst promoter-reporter gene activity in the agr mutant of strain
Newman (Fig. 4), indicating that the glucose-mediated repres-
sion by CcpA remained functional in the agr mutant. This
suggests that expression of tst depends on dual, direct RNAIII
stimulation and glucose-mediated CcpA repression and on in-
direct CcpA-mediated control of RNAIII levels. However, we
cannot rule out that additional factors may influence tst tran-
scription, as N315 differs in terms of metabolism from strain
Newman by being unable to catabolize acetate in the post-
exponential growth phase (36). This loss of secondary metab-
olite catabolism might have consequences on tst expression.
Also, regulatory circuits which may be present in strain N315
but not in the other strains could be the reason for the low tst
expression in N315.
Conclusion. The expression of S. aureus virulence genes is
regulated by complex networks in which global regulators
such as the agr system and the sarA family play a central
role. We recently showed that CcpA is also involved in the
regulation of major virulence determinants by influencing
the expression of hla, spa, and RNAIII (35). By demonstrat-
ing that the expression of tst is affected by CcpA as well, we add
another important virulence factor to the group of CcpA-regu-
lated genes/operons. The significance of glucose-mediated
TSST-1 expression in vivo is unknown and remains to be evalu-
ated using appropriate S. aureus constructs in wild-type and dia-
betic animal pathogenesis models, with the latter elaborating el-
evated blood glucose levels.
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